Medpace Holdings (MEDP) Net Income towards Common Stockholders (2015 - 2026)

Medpace Holdings (MEDP) has 12 years of Net Income towards Common Stockholders data on file, last reported at $121.4 million in Q2 2026.

• Quarterly Net Income towards Common Stockholders rose 34.46% year-over-year to $121.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $491.5 million (up 17.5% YoY) and the FY2025 annual result came in at $451.1 million, up 11.56% from the prior year.
• Net Income towards Common Stockholders eased to $121.4 million in Q2 2026, from $123.9 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $135.1 million in Q4 2025 to a low of $49.4 million in Q2 2022.
• A 5-year average of $90.5 million and a median of $89.3 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders surged 49.45% — and 2025, when it rose 2.16%.
• Tracing MEDP's Net Income towards Common Stockholders over 5 years: stood at $68.7 million in 2022, then climbed by 14.02% to $78.3 million in 2023, then surged by 49.45% to $117.0 million in 2024, then increased by 15.48% to $135.1 million in 2025, then fell by 10.19% to $121.4 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $121.4 million (Q2 2026), $123.9 million (Q1 2026), and $135.1 million (Q4 2025), per Business Quant data.